Cencora (COR) completed the acquisition of Retina Consultants of America for $4.4 billion in cash, subject to a customary post-closing price adjustment.
Fiscal 2025 adjusted earnings guidance was boosted to the range of $15.15 to $15.45 a share from $14.80 to $15.10 to reflect the acquisition, Cencora said Thursday in a statement.
The company acquired 85% in RCA, while some RCA physicians and managers retained a minority stake.